Janux Therapeutics, Inc. (JANX)
18.00
-0.78
(-4.15%)
USD |
NASDAQ |
Aug 28, 16:00
18.21
+0.21
(+1.17%)
After-Hours: 18:32
Janux Therapeutics Total Assets (Quarterly) : 1.008B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.008B |
| March 31, 2026 | 1.028B |
| December 31, 2025 | 1.008B |
| September 30, 2025 | 1.025B |
| June 30, 2025 | 1.032B |
| March 31, 2025 | 1.051B |
| December 31, 2024 | 1.062B |
| September 30, 2024 | 695.02M |
| June 30, 2024 | 691.41M |
| March 31, 2024 | 688.98M |
| December 31, 2023 | 380.41M |
| September 30, 2023 | 386.85M |
| Date | Value |
|---|---|
| June 30, 2023 | 341.50M |
| March 31, 2023 | 352.96M |
| December 31, 2022 | 364.01M |
| September 30, 2022 | 375.76M |
| June 30, 2022 | 385.36M |
| March 31, 2022 | 368.60M |
| December 31, 2021 | 379.82M |
| September 30, 2021 | 391.08M |
| June 30, 2021 | 396.82M |
| March 31, 2021 | 71.82M |
| December 31, 2020 | 16.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MacroGenics, Inc. | 345.41M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 79.67M |
| Shareholders Equity (Quarterly) | 927.98M |
| Debt to Equity Ratio | 0.0226 |
| Current Ratio | 16.35 |
| Net Debt Paydown Yield | 0.03% |